The U.S. Acromegaly Drugs market was valued at USD 759.71 Million in 2023 and is expected to reach USD 1,247.90 Million by 2031, growing at a CAGR of 6.4% (2024-2031). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.